Skip to content

Early Beta blocker Administration before reperfusion in patients with ST-Elevation Myocardial Infarction who are planned to undergo primary PCI.

Early Beta blocker Administration before reperfusion in patients with ST-Elevation Myocardial Infarction who are planned to undergo primary PCI.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24992
Enrollment
408
Registered
2010-10-18
Start date
2010-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardioal infarction, rescue PCI, prehospital treatment. Myocard infarkt Hartinfarkt

Interventions

5 mg intravenous Metoprolol or matching placebo before reperfusion in the ambulance.

Sponsors

Maatschap Cardiologie Isala klinieken Zwolle
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients ≥ 18 years of age with symptoms of acute ST-elevation myocardial infarction of more than 30 min but less than 12 hours and on the ECG ST-segment elevation of ≥0.1 mV in two adjacent limb electrocardiograph (ECG) leads and ≥0.2 mV in two adjacent precordial ECG leads or new left bundle branch block (LBBB). 2. Verbal followed by written informed consents. 3. PCI-center located within 90 minutes

Exclusion criteria

Exclusion criteria: 1. Severe Hypotension (systolic blood pressure 110/min) 3. Known with asthma 4. Severe bradycardia at sinusrythm (240 ms or second- and/or third degree atrio-ventricular (AV) block 6. History of previous myocardial infarction 7. Killip class III-IV 8. Pacemaker/implantable cardioverter defibrillator (ICD) 9. Unable to provide informed consent 10. Patient is pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frame
Infarct size as measured by MRI 1 month post MI.

Secondary

MeasureTime frame
1. Troponin-T after 24 hour of hospitalization 2. Peak CK within hospitalization period 3. Area under CK and CK-MB curve within hospitalization period. 4. Residual ST deviation 1 hr after CAG/PCI 5. Ventricular Fibrillation requiring defibrillation during transportation and hospitalization 6. MACE at 30 days and one year FUP Safety End Points: 1. The incidence of severe bradycardia, asthma or cardiogenic shock 2. 30 day and one year total mortality

Contacts

Public ContactSonja Postma

Dokter Stolteweg 96

s.postma@diagram-zwolle.nl+31 (0)38 4262999

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)